Table II.
Pathways selected with signaling pathway impact analysis.
| Name | P-value | Status | Function |
|---|---|---|---|
| Mitogen-activated protein kinases signaling pathway | 0.011 | Inhibited | Environmental information processing; signal transduction |
| Cytokine-cytokine receptor interaction | 0.017 | Inhibited | Environmental information processing; signaling molecules and interaction |
| Basal cell carcinoma | 0.025 | Inhibited | Human diseases; cancers |
| Dilated cardiomyopathy | 0.021 | Activated | Human diseases; cardiovascular diseases |
| Amoebiasis | 0.023 | Inhibited | Human diseases; infectious diseases |
| Human T-cell leukemia virus type I infection | 0.039 | Inhibited | Human diseases; infectious diseases |
| Gastric acid secretion | 0.008 | Inhibited | Organismal systems; digestive system |
| Cholinergic synapse | 0.042 | Inhibited | Organismal systems; nervous system |